What Can We Learn from Sex Differences in MS?

Overview

Journal J Pers Med

Date 2021 Oct 23

PMID 34683148

Citations 30

Authors

Patricia K Coyle

Affiliations

Soon will be listed here.

Abstract

Multiple sclerosis (MS) is the major acquired central nervous system disease of young adults. It is a female predominant disease. Multiple aspects of MS are influenced by sex-based differences. This has become an important area of research and study. It teaches us how the impact of sex on a disease can lead to new insights, guidelines, management, and treatments.

Citing Articles

Age and sex as key determinants of multiple sclerosis incidence in Spain: a comprehensive analysis using the global burden of disease database (1990-2019).

Cayuela L, Garcia-Munoz C, Cayuela A Neurol Sci. 2024; 46(3):1277-1284.

PMID: 39613940 DOI: 10.1007/s10072-024-07899-6.

Improvement in depressive symptoms is associated with sustained improvement in fatigue impact in adults with multiple sclerosis.

Knowles L, Mistretta E, Arewasikporn A, Hugos C, Cameron M, Haselkorn J Mult Scler Relat Disord. 2024; 92():106158.

PMID: 39577297 PMC: 11737376. DOI: 10.1016/j.msard.2024.106158.

Global burden of multiple sclerosis and its attributable risk factors, 1990-2019.

Safiri S, Ghaffari Jolfayi A, Mousavi S, Nejadghaderi S, Sullman M, Kolahi A Front Neurol. 2024; 15:1448377.

PMID: 39524915 PMC: 11545682. DOI: 10.3389/fneur.2024.1448377.

Engineered Immune Constructs Alter Antigen-Specific Immune Tolerance and Confer Durable Protection in Myelin-Driven Autoimmunity.

Ackun-Farmmer M, Willson Shirkey M, Oakes R, Shah S, Edwards C, Kapnick S ACS Nano. 2024; 18(46):31780-31793.

PMID: 39520377 PMC: 11688820. DOI: 10.1021/acsnano.4c06667.

Biopsychosocial Impact of Multiple Sclerosis in Omani Patients: A Multicenter Comparative Study.

Al-Dhahri M, Helmy M, Rajeev N, Al Toubi A, Al-Abdali H, Al-Asmi A J Clin Med. 2024; 13(21).

PMID: 39518455 PMC: 11546824. DOI: 10.3390/jcm13216315.

References

Wingerchuk D, Rodriguez M . Premenstrual multiple sclerosis pseudoexacerbations: Role of body temperature and prevention with aspirin. Arch Neurol. 2006; 63(7):1005-8. DOI: 10.1001/archneur.63.7.1005. View

Rae-Grant A, Day G, Marrie R, Rabinstein A, Cree B, Gronseth G . Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018; 90(17):777-788. DOI: 10.1212/WNL.0000000000005347. View

Thompson A, Banwell B, Barkhof F, Carroll W, Coetzee T, Comi G . Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2017; 17(2):162-173. DOI: 10.1016/S1474-4422(17)30470-2. View

Lublin F, Reingold S, Cohen J, Cutter G, Soelberg Sorensen P, Thompson A . Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014; 83(3):278-86. PMC: 4117366. DOI: 10.1212/WNL.0000000000000560. View

Comi G, Hartung H, Bakshi R, Williams I, Wiendl H . Benefit-Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis. Drugs. 2017; 77(16):1755-1768. PMC: 5661009. DOI: 10.1007/s40265-017-0814-1. View

Roeder H, Leira E . Effects of the Menstrual Cycle on Neurological Disorders. Curr Neurol Neurosci Rep. 2021; 21(7):34. DOI: 10.1007/s11910-021-01115-0. View

Hviid A, Molgaard-Nielsen D . Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ. 2011; 183(7):796-804. PMC: 3080529. DOI: 10.1503/cmaj.101063. View

Yland J, Bresnick K, Hatch E, Wesselink A, Mikkelsen E, Rothman K . Pregravid contraceptive use and fecundability: prospective cohort study. BMJ. 2020; 371:m3966. PMC: 7656314. DOI: 10.1136/bmj.m3966. View

Thone J, Kleiter I, Stahl A, Ellrichmann G, Gold R, Hellwig K . Relevance of endoglin, IL-1α, IL-1β and anti-ovarian antibodies in females with multiple sclerosis. J Neurol Sci. 2016; 362:240-3. DOI: 10.1016/j.jns.2016.01.057. View

10.

Magyari M, Soelberg Sorensen P . The changing course of multiple sclerosis: rising incidence, change in geographic distribution, disease course, and prognosis. Curr Opin Neurol. 2019; 32(3):320-326. DOI: 10.1097/WCO.0000000000000695. View

11.

Golden L, Voskuhl R . The importance of studying sex differences in disease: The example of multiple sclerosis. J Neurosci Res. 2016; 95(1-2):633-643. PMC: 5825192. DOI: 10.1002/jnr.23955. View

12.

Antulov R, Weinstock-Guttman B, Cox J, Hussein S, Durfee J, Caiola C . Gender-related differences in MS: a study of conventional and nonconventional MRI measures. Mult Scler. 2008; 15(3):345-54. DOI: 10.1177/1352458508099479. View

13.

Voskuhl R, Patel K, Paul F, Gold S, Scheel M, Kuchling J . Sex differences in brain atrophy in multiple sclerosis. Biol Sex Differ. 2020; 11(1):49. PMC: 7456053. DOI: 10.1186/s13293-020-00326-3. View

14.

Pecori C, Giannini M, Portaccio E, Ghezzi A, Hakiki B, Pasto L . Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study. BMC Neurol. 2014; 14:114. PMC: 4059028. DOI: 10.1186/1471-2377-14-114. View

15.

Dobson R, Giovannoni G, Ramagopalan S . The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude. J Neurol Neurosurg Psychiatry. 2012; 84(4):427-32. DOI: 10.1136/jnnp-2012-303934. View

16.

Sepulveda M, Ros C, Martinez-Lapiscina E, Sola-Valls N, Hervas M, Llufriu S . Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: A pilot study. Mult Scler. 2015; 22(4):564-8. DOI: 10.1177/1352458515602339. View

17.

Dobson R, Jokubaitis V, Giovannoni G . Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis. Mult Scler Relat Disord. 2020; 44:102241. DOI: 10.1016/j.msard.2020.102241. View

18.

Bove R, Okai A, Houtchens M, Elias-Hamp B, Lugaresi A, Hellwig K . Effects of Menopause in Women With Multiple Sclerosis: An Evidence-Based Review. Front Neurol. 2021; 12:554375. PMC: 8017266. DOI: 10.3389/fneur.2021.554375. View

19.

Westerlind H, Stawiarz L, Fink K, Hillert J, Manouchehrinia A . A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort study. Mult Scler. 2016; 22(8):1071-9. DOI: 10.1177/1352458516643394. View

20.

Marrie R, Rudick R, Horwitz R, Cutter G, Tyry T, Campagnolo D . Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology. 2010; 74(13):1041-7. PMC: 2848107. DOI: 10.1212/WNL.0b013e3181d6b125. View